A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine: A Case Report

J Clin Psychopharmacol. 2022 Jul-Aug;42(4):422-424. doi: 10.1097/JCP.0000000000001568. Epub 2022 Jun 2.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cannabidiol* / pharmacology
  • Cytochrome P-450 CYP2D6 / genetics
  • Cytochrome P-450 CYP2D6 Inhibitors
  • Drug Interactions
  • Fluoxetine* / pharmacology
  • Humans
  • Paroxetine
  • Selective Serotonin Reuptake Inhibitors / pharmacology

Substances

  • Cytochrome P-450 CYP2D6 Inhibitors
  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Cannabidiol
  • Paroxetine
  • Cytochrome P-450 CYP2D6